As of April 16, 2025, Sutro Biopharma (STRO) has a market cap of $48.548 million USD. According to our data, Sutro Biopharma is ranked No.8090 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $48.55 M |
-68.00%
|
Dec 31, 2024 | $0.15 B |
-57.11%
|
Dec 29, 2023 | $0.35 B |
-46.91%
|
Dec 30, 2022 | $0.67 B |
-45.70%
|
Dec 31, 2021 | $1.23 B |
-31.46%
|
Dec 31, 2020 | $1.79 B |
97.36%
|
Dec 31, 2019 | $0.91 B |
21.95%
|
Dec 31, 2018 | $0.74 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.02 B |
-0.124 B
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.31 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Blueprint Medicines
BPMC
|
$5.16 B |
-0.043 B
|
![]() USA
|
![]() Exelixis
EXEL
|
$10.18 B |
-0.045 B
|
![]() USA
|
![]() MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
![]() USA
|
![]() Nektar Therapeutics
NKTR
|
$0.12 B |
0.000 M
|
![]() USA
|
Market Cap | = | STRO Stock Price | * | STRO Shares Outstanding |
= | $0.58 | * | 83.78 M | |
= | $48.55 M |